The one-third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum take topographic point from November 19 to 21, 2021. China’s large health industry, the universe’s second-large checkup market, is entrance a aureate decade amidst the challenge show by the superintendent ripening society in China. The Healthy China 2030 enterprise align with the fourteenth Five-Year Plan, emphasizing invention as crucial for the industry’s growth.
The” Guangdong, Hong Kong, and Macao third Greater Bay Area Medical Innovation Technology and Market Access acme” was jointly form by the Guangdong Medicine Institute, Guangzhou Biological Industry Alliance, Biomedical Innovation Technology Association of Guangdong Province, and Dongguan Institute, Jinan University. keep in Guangzhou from November 19 to 21, 2021, this forum aim to optimize the development scheme of pharmaceutical enterprise, particularly focus on new merchandise research and development, advanced technology promotion, market entree, and enhance the efficiency of drug R&D personnel.
This acme bring together top checkup insurance expert, checkup policy expert, and pharmaceutical industry leadership to discus technological invention and industry tendency. By fostering collaboration and sharing penetration, the forum not only benefit checkup practitioner and pharmaceutical enterprise but also purpose to establish the Hong Kong and Macao Greater Bay Area as a hub for invention, industry, and endowment within the pharmaceutical sector. This collective attempt seek to progress biomedicine development in China and lend significantly to safeguard people’s health and well-being.